We’re working to bring the hope of advanced medicine to more patients.
Targeting inflammation to fight cancer is a new approach with a long history.
Ad hoc announcement pursuant to article 53 Listing Rules.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.